Estrogen receptor-mediated effects of isoflavone supplementation were not observed in whole-genome gene expression profiles of peripheral blood mononuclear cells in postmenopausal, equol-producing women

Journal of Nutrition

Volumn 143, Issue 6, 2013, Pages 774-780

  van Der Velpen, Vera ^a   Geelen, Anouk ^a   Schouten, Evert G ^a   Hollman, Peter C ^a   Afman, Lydia A ^a   van't Veer, Pieter ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; EQUOL; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; GENISTEIN; GLYCITEIN; ISOFLAVONE;

ADULT; ARTICLE; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; OXIDATIVE PHOSPHORYLATION; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION;

CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EQUOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION; HUMANS; ISOFLAVONES; LEUKOCYTES, MONONUCLEAR; PLACEBOS; POSTMENOPAUSE; RECEPTORS, ESTROGEN; TRANSCRIPTOME;

EID: 84878263035     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.174037     Document Type: Article

References (51)

1. Setchell KD, Clerici C. Equol: history, chemistry, and formation. J Nutr. 2010;140:1355S-62S.
2. Messina M. Insights gained from 20 years of soy research. J Nutr. 2010;140:2289S-95S.
3. Kurzer MS. Phytoestrogen supplement use by women. J Nutr. 2003;133: 1983S-6S.
4. Andres S, Abraham K, Appel KE, Lampen A. Risks and benefits of dietary isoflavones for cancer. Crit Rev Toxicol. 2011;41:463-506.
5. Wuttke W, Jarry H, Seidlova-Wuttke D. Isoflavones-safe food additives or dangerous drugs? Ageing Res Rev. 2007;6:150-88.
6. Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update. 2007;13:559-65.
7. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577-84.
8. Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB, Hur HG, Han KO. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol. 2006;101:246-53.
9. Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LC, Geleijnse JM, Muller M, Afman LA. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr. 2009;90:415-24.
10. Niculescu MD, Pop EA, Fischer LM, Zeisel SH. Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. J Nutr Biochem. 2007;18:380-90.
11. Setchell KD, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr. 2006;136:2188-93.
12. van Dijk SJ, Feskens EJ, Bos MB, de Groot LC, de Vries JH, Muller M, Afman LA. Consumption of a high monounsaturated fat diet reduces oxidative phosphorylation gene expression in peripheral blood mononuclear cells of abdominally overweight men and women. J Nutr. 2012;142:1219-25.
13. Siebelink E, Geelen A, de Vries JH. Self-reported energy intake by FFQ compared with actual energy intake to maintain body weight in 516 adults. Br J Nutr. 2011;106:274-81.
14. National Center for Biotechnology Information. BLAST (Basic Local Alignment Search Tool) [cited 2012 Jul]. Available from: http://blast. ncbi.nlm.nih.gov/Blast.cgi.
15. Penalvo JL, Nurmi T, Adlercreutz H. A simplified HPLC method for total isoflavones in soy products. Food Chem. 2004;87:297-305.
16. Saracino MA, Raggi MA. Analysis of soy isoflavone plasma levels using HPLC with coulometric detection in postmenopausal women. J Pharm Biomed Anal. 2010;53:682-7.
17. MADMAX. Management and Analysis Database for Multi-platform MicroArray eXperiments [cited 2012 Jan]. Available from: https:// madmax.bioinformatics.nl.
18. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185-93.
19. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15.
20. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102: 15545-50.
21. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34: 267-73.
22. GSEA. Gene Set Enrichment Analysis [cited 2012May]. Available from: http://www.broadinstitute.org/gsea/index.jsp.
23. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498-504.
24. Tang S, Han H, Bajic VB. ERGDB: Estrogen-Responsive Genes Database. Nucleic Acids Res. 2004;32:D533-6.
25. Oliveros J. VENNY: an interactive tool for comparing lists with Venn diagrams. 2007 [cited 2012 Oct]. Available from: http://bioinfogp.cnb. csic.es/tools/venny/index.html.
26. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30:465-93.
27. MedlinePlus. Estradiol test. Medline Plus 2012 [cited 2012 Jan 10]. Available from: http://www.nlm.nih.gov/medlineplus/ency/article/ 003711.htm.
28. Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13:816-25.
29. Virk-Baker MK, Nagy TR, Barnes S. Role of phytoestrogens in cancer therapy. Planta Med. 2010;76:1132-42.
30. Beavers KM, Jonnalagadda SS, Messina MJ. Soy consumption, adhesion molecules, and pro-inflammatory cytokines: a brief review of the literature. Nutr Rev. 2009;67:213-21.
31. Wu SH, Shu XO, Chow WH, Xiang YB, Zhang X, Li HL, Cai Q, Ji BT, Cai H, Rothman N, et al. Soy food intake and circulating levels of inflammatory markers in chinese women. J Acad Nutr Diet. 2012;112: 996-1004.
32. Charles C, Yuskavage J, Carlson O, John M, Tagalicud AS, Maggio M, Muller DC, Egan J, Basaria S. Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause. 2009;16:395-400.
33. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420: 860-7.
34. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83 Suppl:456S-60S.
35. Mundy GR. Osteoporosis and inflammation. Nutr Rev. 2007;65: S147-51.
36. Koopman WJH, Nijtmans LGJ, Dieteren CEJ, Roestenberg P, Valsecchi F, Smeitink JAM,Willems PHGM. Mammalian mitochondrial complex i: biogenesis, regulation, and reactive oxygen species generation. Antioxid Redox Signal. 2010;12:1431-70.
37. Dizdaroglu M, Jaruga P. Mechanisms of free radical-induced damage to DNA. Free Radic Res. 2012;46:382-419.
38. Ewen ME. Where the cell cycle and histones meet. Genes Dev. 2000;14: 2265-70.
39. Hedlund TE, Johannes WU, Miller GJ. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate. 2003;54:68-78.
40. Medjakovic S, Mueller M, Jungbauer A. Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR. Nutrients. 2010;2:241-79.
41. Wierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem. 2007;388:1257-74.
42. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100: 57-70.
43. Meeran SM, Katiyar SK. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci. 2008;13: 2191-202.
44. Boniglia C, Carratu B, Gargiulo R, Giammarioli S, Mosca M, Sanzini E. Content of phytoestrogens in soy-based dietary supplements. Food Chem. 2009;115:1389-92.
45. Bunce CM, Campbell MJ, Nilsson S, Gustafsson J-A. Estrogen receptors: their actions and functional roles in health and disease. In: Ridley A, Frampton J, editors. Nuclear receptors. Houten (Netherlands): Springer Netherlands; 2010. p. 91-141.
46. Steiner C, Arnould S, Scalbert A, Manach C. Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics. Br J Nutr. 2008;99 E Suppl 1:ES78-108.
47. Phiel KL, Henderson RA, Adelman SJ, Elloso MM. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett. 2005;97:107-13.
48. Scariano JK, Emery-Cohen AJ, Pickett GG, Morgan M, Simons PC, Alba F. Estrogen receptors alpha (ESR1) and beta (ESR2) are expressed in circulating human lymphocytes. J Recept Signal Transduct Res. 2008;28:285-93.
49. Stygar D, Masironi B, Eriksson H, Sahlin L. Studies on estrogen receptor (ER) alpha and beta responses on gene regulation in peripheral blood leukocytes in vivo using selective ER agonists. J Endocrinol. 2007;194:101-19.
50. Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol. 2011;7:715-26.
51. Drew JE. Cellular defense system gene expression profiling of human whole blood: opportunities to predict health benefits in response to diet. Adv Nutr. 2012;3:499-505.